Contineum Therapeutics, Inc. · NASDAQ:CTNM
Watkins Tim sold 10,833 Contineum Therapeutics, Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 1, 2026
On Jun 30, 2026, Watkins Tim (CMO & Head of Development) sold 10,833 Contineum Therapeutics, Inc. shares at US$16.02 for US$174K under a trading plan, leaving 8,961 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 10,833 shares
- Price
- US$16.02
- Value
- US$174K
- Holding after
- 8,961 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CMO & Head of Development
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Class A Common Stock | Option exercise | 10,833 | US$4.50 | 19,794 | Direct |
| Jun 30, 2026 | Class A Common Stock | Sale | 10,833 | US$16.02 | 8,961 | Direct |
Source
Related
- Contineum Therapeutics, Inc.
- Watkins Tim
- Contineum Therapeutics, Inc. shareholders
- Form 4 · Stengone Carmine N. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Stengone Carmine N. · Aug 3, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 17, 2026